Replies to post #116638 on Biotech Values

[jq1234]

Could you imagine what the pps would have been if it had not been approved?

The risk of not approving was very low. The market was correct in predicting approval. In these cases, not much bounce are expected. As always, high risk high reward, low risk low reward. Nothing unusual there.